The market research report on the Global Epilepsy Monitoring Devices Market presents an in-depth information about the various aspects of the market, on both global and regional scales, which provides a better understanding of the present market landscape. The growth of the Epilepsy Monitoring Devices market has been driven by the soaring demand for Epilepsy Monitoring Devices in the well-established and emerging regions, current technological advancements, and the growing infiltration of the end-use industries.

The report "Epilepsy Monitoring Devices Market by Product (Conventional & Wearable Devices, Standard EEG, Video EEG, Ambulatory EEG, EMG, MEG, Deep Brain Stimulation Devices) End User (Hospitals, Neurology Centres, ASC, Home Care Settings) - Global Forecast to 2026" The global epilepsy monitoring devices market is projected to reach USD 615 million by 2026 from USD 489 million in 2021, at a CAGR of 4.7% during the forecast period. The growth of this market is majorly attributed to the increasing incidence and prevalence of epilepsy, growing preference for ambulatory healthcare and increasing use of wearables, growing demand for continuous monitoring, and the rising awareness of neurodegenerative diseases, including epilepsy. On the other hand, the high cost of complex epilepsy monitoring procedures and devices and the unfavorable reimbursement policies are restraining the growth of this market.

Download a PDF Copy:

The report presents some illustrations and presentations with regard to the market, which includes graphs, tables and pie charts, representing the percentage split of the strategies adopted by the key players in the global market. The product launches are regarded as one of the key strategies adopted by the leading market competitors in the Global Epilepsy Monitoring Devices Market so as to present novel and innovative products in different business segments.

Natus Medical, Inc. (US), Compumedics Limited (Australia), The Magstim Co. Ltd. (UK), Nihon Kohden Corporation (Japan), and Masimo Corporation (US) were the top players in the epilepsy monitoring devices market during the forecast period. Other major players in the market include Empatica, Inc. (US), Medtronic Plc (Ireland), Boston Scientific Corporation (US), Drägerwerk AG & Co. KGaA (Germany), mjn Neuroserveis S.L. (Spain), Abbott Laboratories, Inc. (US), LivAssured B.V. (Netherlands), BioSerenity (France), Aleva Neurotherapeutics (Switzerland), Medpage, Ltd. (UK), Neurosoft (Russia).

The research report categorizes the Epilepsy monitoring devices market into the following segments and subsegments:

By Product

  • Wearable Devices
  • Conventional Devices
    • Deep Brain Stimulation Devices
    • Monitoring Devices
      • EEG Devices
        • Standard EEG
        • Video EEG
        • Others/Ambulatory EEG
      • EMG Devices
      • MEG Devices
      • Other Monitoring Devices

By End User

  • Hospitals
  • Ambulatory Surgery Centers & Clinics
  • Neurology Centres
  • Diagnostic Centres
  • Home Care Settings

Some of the key geographies mentioned in this report include:

  • North America (U.S and Canada and rest of North America)
  • Europe (Germany, France, Italy and Rest of Europe)
  • Asia-Pacific (China, Japan, India, South Korea and Rest of Asia-Pacific)
  • LAMEA (Brazil, Turkey, Saudi Arabia, South Africa and Rest of LAMEA)

Recent Developments

  • In February 2021, BioSerenity and Premier Inc. entered into an agreement where the former was to serve as Premier’s contracted provider and serve approximately 4,000 US hospitals and 175,000 other providers.
  • In January 2021, Nihon Kohden launched disposable EEG electrodes to help prevent cross-contamination between patients and healthcare workers while maintaining high-quality EEG signals.
  • In July 2020, Magstim acquired Philips’ subsidiary, EGI, adding high-density EEG solutions to its product portfolio. This acquisition helped the company close the loop for the development of a comprehensive system for non-invasive neuromodulation.
  • In May 2020, Natus Medical announced a partnership with Holberg to develop and distribute the Autoscore algorithm. The algorithm helps automate electroencephalography (EEG) classifications and advance reporting efficiency.

Key Deliverables in the Study:

  • Overall market landscape for the Global Epilepsy Monitoring Devices Market, along with the regional analysis and competitive analysis, based on the regional and global scales.
  • Market definition and market dynamics, including drivers, restraints, challenges, threats, and potential growth opportunities.
  • Factors responsible for changing the market landscape, soaring opportunities, and identification of leading competitors that will impact the growth of the market on a regional and global scale.
  • Detailed analysis of the leading industry participants along with their company profiles, supply chain trends, technological advancements, inventions, and key developments.
  • In-depth analysis of the macro- and micro factors that will have an impact on the growth of the market, on a regional and global scale.
  • Detailed assessment of the financial information and the current strategies of the leading key players functioning in the market.
  • An in-depth understanding and insights about the key industry players and the strategies adopted by them to sustain and grow in the Global Epilepsy Monitoring Devices Market.

Research Study Source: